1/14
09:20 pm
atra
Form SCHEDULE 13D/A Atara Biotherapeutics, Filed by: Panacea Innovation Ltd
Low
Report
Form SCHEDULE 13D/A Atara Biotherapeutics, Filed by: Panacea Innovation Ltd
1/14
09:16 pm
atra
Form 4 Atara Biotherapeutics, For: Jan 12 Filed by: Huang James
Low
Report
Form 4 Atara Biotherapeutics, For: Jan 12 Filed by: Huang James
1/12
09:26 pm
atra
Form 144 Atara Biotherapeutics, Filed by: Panacea Innovation Ltd
High
Report
Form 144 Atara Biotherapeutics, Filed by: Panacea Innovation Ltd
1/12
04:00 pm
atra
Form 8-K Atara Biotherapeutics, For: Jan 12
High
Report
Form 8-K Atara Biotherapeutics, For: Jan 12
1/2
04:02 pm
atra
Form 8-K Atara Biotherapeutics, For: Dec 30
Medium
Report
Form 8-K Atara Biotherapeutics, For: Dec 30
12/1
05:00 pm
atra
Form 4 Atara Biotherapeutics, For: Nov 28 Filed by: Huang James
High
Report
Form 4 Atara Biotherapeutics, For: Nov 28 Filed by: Huang James
11/19
04:55 pm
atra
Form 4 Atara Biotherapeutics, For: Nov 17 Filed by: Nguyen AnhCo
Medium
Report
Form 4 Atara Biotherapeutics, For: Nov 17 Filed by: Nguyen AnhCo
11/19
04:55 pm
atra
Form 4 Atara Biotherapeutics, For: Nov 17 Filed by: Grant-Huerta Yanina
Medium
Report
Form 4 Atara Biotherapeutics, For: Nov 17 Filed by: Grant-Huerta Yanina
11/17
05:52 pm
atra
Form 144 Atara Biotherapeutics, Filed by: Nguyen AnhCo
Low
Report
Form 144 Atara Biotherapeutics, Filed by: Nguyen AnhCo
11/17
05:50 pm
atra
Form 144 Atara Biotherapeutics, Filed by: Grant-Huerta Yanina
Low
Report
Form 144 Atara Biotherapeutics, Filed by: Grant-Huerta Yanina
11/14
04:26 pm
atra
Form SCHEDULE 13D/A Atara Biotherapeutics, Filed by: Redmile Group, LLC
Medium
Report
Form SCHEDULE 13D/A Atara Biotherapeutics, Filed by: Redmile Group, LLC
11/14
04:08 pm
atra
Form SCHEDULE 13G/A Atara Biotherapeutics, Filed by: EcoR1 Capital, LLC
Medium
Report
Form SCHEDULE 13G/A Atara Biotherapeutics, Filed by: EcoR1 Capital, LLC
11/12
09:11 am
atra
Form 10-Q Atara Biotherapeutics, For: Sep 30
Low
Report
Form 10-Q Atara Biotherapeutics, For: Sep 30
11/12
09:05 am
atra
Form 8-K Atara Biotherapeutics, For: Nov 12
Low
Report
Form 8-K Atara Biotherapeutics, For: Nov 12